Home | All secondary_outcomes

[RDF data]
Secondary Outcomes #100325

Resource URI: http://static.linkedct.org/resource/secondary_outcomes/100325
PropertyValue
rdfs:label Secondary Outcomes #100325
linkedct:measure Safety & tolerabilty: 1. treatment-emergent AE(s) 2. clinically significant changes in safety labs, PE, vital signs and 3. development of anti-AMG 827 antibodies.
linkedct:safety_issue Yes
is linkedct:secondary_outcomes of <http://static.linkedct.org/resource/trials/NCT00771030>
linkedct:secondary_outcomes_id 100325 (xsd:int)
linkedct:time_frame 18 weeks
rdf:type linkedct:secondary_outcomes